JOYCE J GONZALES

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family IOLA, KS NPI 1851661243

General Payments — all program years on this page

$3,901.71

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 230
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $453.84 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $453.8418

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $167.173
Lilly USA, LLC $101.115
Novo Nordisk AS $72.974
Amgen Inc. $36.662
BOSTON SCIENTIFIC CORPORATION $22.031
Ardelyx, Inc. $19.321
Abbott Laboratories $17.951
DEXCOM, INC. $16.631

By program year

Program yearAmountRecords
2021 $1,336.5683
2022 $1,174.5374
2023 $936.7855
2024 $453.8418

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092574295 Boston Scientific Corporation $22.03 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100316642 Novo Nordisk Inc $17.63 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100394610 Novo Nordisk Inc $14.95 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100568042 Novo Nordisk Inc $22.55 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100596327 Novo Nordisk Inc $17.84 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104428419 AstraZeneca Pharmaceuticals LP $15.93 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104439249 AstraZeneca Pharmaceuticals LP $29.65 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104673783 AstraZeneca Pharmaceuticals LP $121.59 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117564532 Amgen Inc. $18.68 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117564534 Amgen Inc. $17.98 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125305257 Abbott Laboratories $17.95 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135647083 Lilly USA, LLC $19.47 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135647085 Lilly USA, LLC $19.48 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135660819 Lilly USA, LLC $23.22 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135715872 Lilly USA, LLC $19.47 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135730214 Lilly USA, LLC $19.47 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146728172 Ardelyx, Inc. $19.32 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153368217 Dexcom, Inc. $16.63 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.